Who Should Care? This update primarily affects Chinese business executives and investors applying for US visas, especially the L-1 intracompany transferee and EB-1C multinational executive categories. These clients often undergo rigorous medical examinations as part of their visa process. Additionally, EB-5 investors and their families, who require medical clearance for immigrant visa issuance, should also pay attention.

What Has Changed? According to recent reports, US consular posts will begin denying visas to applicants diagnosed with certain chronic illnesses including diabetes, heart disease, and other conditions deemed potentially burdensome to public health or safety. This policy aligns with the medical inadmissibility grounds under INA §212(a)(1)(A) and is detailed in the Foreign Affairs Manual (FAM) 42.53.

From our practical experience, while medical conditions have always been a factor in visa adjudication, this update signals a stricter enforcement trend. For example, in several recent L-1B visa cases involving executives with controlled diabetes, consulates requested extensive additional medical documentation or outright issued refusals without waivers.

Step-by-Step Action Plan

  1. 1Review Medical Records Early: We advise clients to obtain full medical evaluations from US-approved physicians before filing visa petitions. This allows time to identify any disqualifying conditions and prepare accordingly.
  1. 1Engage Experienced Immigration Counsel: Medical inadmissibility can be waived under specific circumstances (8 CFR 212.7), but waiver eligibility criteria are strict. Our team helps prepare detailed waiver applications demonstrating that the applicant’s condition is well-controlled and poses no risk to public health.
  1. 1Coordinate with Employers and Project Teams: For L-1 and EB-1C applicants, it is crucial that HR and legal teams factor medical issues early in the process to avoid delays or denials. For instance, scheduling medical exams well before consular appointments can reduce last-minute surprises.
  1. 1Monitor Consulate-Specific Policies: Some US consulates may interpret these guidelines more rigidly. We recommend tracking consulate bulletins and adjusting interview preparation accordingly.

Real Case Illustration Last quarter, we assisted a fintech executive applying for an L-1A visa who has type 2 diabetes. Initially, the consulate issued an RFE requesting a full medical report. By proactively submitting a detailed endocrinologist’s letter demonstrating stable condition and no complications, we successfully obtained a medical waiver under INA §212(h). This case underlines the importance of early preparation and expert legal support.

What This Means for You If you are a Chinese executive or investor planning to apply for US visas, do not wait until the last minute to address medical issues. Early medical evaluation, coupled with strategic legal planning, can safeguard your visa approval chances despite the tightened scrutiny on chronic illnesses. Our firm is ready to assist you in navigating these challenges with tailored solutions.

Remember, the key is preparation and informed response, turning a potential obstacle into a manageable step in your immigration journey.